Cell Biotech DUOLAC Wraps Up ‘Focus Seminar 2025’ for Pharmacists with Strong Attendance of 1,000 Nationwide

DUOLAC, Cell Biotech’s probiotic brand widely recognized as the “221x stronger probiotic,” has successfully concluded its ‘Focus Seminar 2025,’ held nationwide across 16 regions from February to November this year. A total of 32 sessions were conducted, drawing 1,000 pharmacists in attendance and reaffirming DUOLAC’s credibility and influence as a pharmacy-based professional brand.

For over 30 years, Cell Biotech has focused exclusively on the research and development of Korean-origin probiotic strains, concentrating on the pharmacy distribution channel to foster a consultation-centered health supplement culture built on professionalism and trust. This strategy differentiates the company from offline retail trends that emphasize convenience—such as convenience stores and general merchandise outlets—and instead strengthens a market structure in which consumers can select probiotics tailored to individual needs through professional pharmacist consultation.

DUOLAC holds multiple global certifications, including U.S. FDA GRAS, GMP, Kosher, and HALAL, underscoring the brand’s strong safety and quality credentials. Leveraging its proprietary CBT strain formula, DUOLAC has established a pharmacy-exclusive premium lineup comprising ‘Gold D-Drops,’ ‘Gold Baby,’ ‘Gold Kids,’ and ‘DUOLAC Gold,’ further solidifying its presence in the pharmacy market. In particular, DUOLAC’s dual-coating technology, which maximizes probiotic survivability and is often referred to as the “221x stronger probiotic,” attracted the greatest interest from participating pharmacists.

First launched in 2007, the Focus Seminar has become DUOLAC’s flagship educational program, contributing to the enhancement of pharmacists’ professional expertise by sharing the latest probiotic research, counseling insights, and product knowledge. This year, the seminar was recognized by local pharmaceutical associations as an “Exemplary Academic Seminar,” and received strong on-site evaluations, with continued requests for additional sessions.

Lee Hye-jeong, a pharmacist who participated as a seminar lecturer, commented,

“It was truly meaningful to engage in in-depth discussions while sharing the latest research trends in probiotics with fellow pharmacists. I hope that a culture in which consumers select probiotics that best suit their needs through professional pharmacist consultation continues to expand.”

She added,

“DUOLAC’s commitment to ongoing research and its continued investment in educational programs for pharmacy professionals clearly demonstrate its strength as a specialized probiotic brand. I am very much looking forward to the new products and initiatives DUOLAC will introduce in the future.”

A Cell Biotech official stated,

“For the past 30 years, DUOLAC has grown alongside pharmacies based on its research into Korean-origin probiotic strains. This year’s Focus Seminar served as an important platform for strengthening professional collaboration with pharmacists.”

The official also emphasized,

“In 2026, we will continue to lead the expansion of a healthy probiotic consumption culture by broadening our pharmacy-exclusive product offerings and operating structured, high-quality seminar programs.”

Cell Biotech plans to continue hosting the ‘Focus Seminar’ for pharmacists in 2026, further accelerating the revitalization of the pharmacy-based health supplement market and strengthening its nationwide pharmacist network.